29-Nov-2021: Technology One (TechOne, ASX:TNE) released their FY21 full year results on Tuesday morning last week, and their SP dropped -2.86% (or -37 cps) on the day, then their SP dropped another -8.61% on Wednesday (24 Nov) as two brokers downgraded their calls on TNE. Macquarie dowgraded TNE from "Neutral" to "Underperform" with a new $11 TP (target price) and UBS dowgraded TNE from "Neutral" to "Sell" with an $11.90 TP. It didn't seem to help that Morgans maintained their "Add" call on TNE with a $13.73 TP (raised from their previous $10 PT). The other broker covered by fnarena.com who covers TNE is Credit Suisse who maintained their "Neutral" rating with a $12 PT. See below:
I note that as of right now (around 3pm on 29-Nov-2021), fnarena.com have not yet added TNE's FY21 numbers to those graphs in the top half of that screenshot. The broker updates at the bottom ARE up to date however. (As of today at least)
Here's some more detail:
Macquarie - 24/11/2021, Downgrade to Underperform from Neutral, Target: $11.00, Loss to target $-0.47
Following FY21 results for TechnologyOne, Macquarie raises its FY22-24 EPS forecasts by 10%, 15% and15%, respectively, due primarily to lower opex. The broker lifts its target to $11 from $9.20 and notes solid momentum in the SaaS transition.
However, Macquarie reduces its rating to Underperform from Neutral after comparing multiples for domestic and overseas peers. Management's lower revenue growth forecast was also taken into account.
Target price : $11.00 Price : $11.47 (24/11/2021) Loss to target $-0.47 -4.10%
(excluding dividends, fees and charges - negative figures indicate an expected loss).
UBS - 24/11/2021, Downgrade to Sell from Neutral, Target: $11.90, Gain to target $0.43
UBS assesses a solid FY21 result for TechologyOne though downgrades its rating to Sell from Neutral after a 30% share rally in the last three months. The profit result was a 1% beat versus the broker and towards the top end of guidance, primarily due to cost efficiencies.
Management reiterated the FY26 $500m annual reccuring revenue (ARR) target, after progress on SaaS transitions during 2H21, points out the analyst. The broker lifts its target price to $11.90 from $11.70.
Target price : $11.90 Price : $11.47 (24/11/2021) Gain to target $0.43 3.75%
(excluding dividends, fees and charges - negative figures indicate an expected loss).
Morgans - 24/11/2021, Add, Target: $13.73, Gain to target $2.26
TechnologyOne's profit result was in line with Morgans' forecast and towards the top end of the guiidance range. Both revenues and expenses were lower than forecast but tight cost controls supported earnings.
The transition of customers to SaaS continues with SaaS annual recurring revenue up an "impressive" 43% year on year. The legacy on-premise business will be disconinued in 2024 and management remains comfortable with its $500m SaaS ARR target for 2026.
Add retained, target rises to $13.73 from $10.00.
Target price : $13.73 Price : $11.47 (24/11/2021) Gain to target $2.26 19.70%
(excluding dividends, fees and charges - negative figures indicate an expected loss).
Credit Suisse - 24/11/2021, Neutral, Target: $12.00, Gain to target $0.53
Credit Suisse increases its target price for Technology One to $12 from $9.50, following FY21 results that came in at the high-end of guidance. Despite a lack of near-term catalysts, the analyst now expects sustainable double-digit profit growth.
By FY24, the broker forecasts a 35% profit (PBT) margin. End of on-premise support is planned for October 2024, which should accelerate the completion of the shift to SaaS.
In the longer term, the broker weighs positive drivers (product and geographic penetration) versus increased competition. Neutral rating maintained.
Target price : $12.00 Price : $11.47 (24/11/2021) Gain to target $0.53 4.62%
(excluding dividends, fees and charges - negative figures indicate an expected loss).
--- end --- Source: fnarena.com
The TNE share price was then up +4.27% (or +49 cps) on Thursday, then down -3.34% (or -40 cps) on Friday, and now today they are up +44 cps (or +3.81%) so far, so trading at exactly $12/share as I type this, and they have been as high as $12.19 earlier today. I couldn't really understand the market's negative reaction to the TNE results last week, however it is good to see TNE rising today in a falling market. The cream rises to the top when all is said and done. And TNE is the cream of the ASX IMHO. Disclosure: I hold TNE in multiple RL portfolios as well as here on SM.
As I have stated before, including in my valuation for TNE, they have managed to double their revenue and profits (+100% as a minimum) in a five year period three times already:
Their share price (SP) has reflected that:
30-Nov-2005: $0.57
30-Nov-2010: $0.96
30-Nov-2015: $4.35
30-Nov-2020: $9.18
Today (29-Nov-2021): $12.
As they explained on Tuesday last week:
$500m+ ARR by FY26 - With our fast-growing SaaS business and the announcement of the end of our On-Premise business, we are on track to hit our target of $500m+ ARR by FY26. Given the current ARR is $257.5m, this is an additional $242.5m of Annual Recurring Revenue in the next 5 years.
Revenue from SaaS & Continuing Business was up 9% [in FY21]. This is our future state business. By FY24 we expect our total business to be growing by 15%+ per annum.
Some people might call this optimistic, but TNE have a track record of achieving their own ambitious targets.
Rudi put it best: https://www.fnarena.com/index.php/2020/12/03/rudis-view-be-respectful-of-the-past/
I agree with Rudi that TNE is one of the best quality companies available to invest in on the ASX, and has been for a number of years. If you are after good growth year after year and a company that sets ambitious targets and then hits those targets, then TNE fits the bill perfectly.
That said, I'm possibly not going to be topping up here at these levels because I last bought TNE shares in January 2021 (this year) at $7.74, and they had significantly more shorter and mid-term upside from those sub-$8 levels than do up here at around $12/share, plus I have a large enough weighting to the company already, particularly considering the capital growth I've enjoyed. If I was underweight TNE shares however, these levels would look pretty good if you take a medium to longer term view, say 3 to 5 years.
Sample photo from their media kit - see here: Media Kit - TechnologyOne (technologyonecorp.com)
Edward Chung (CEO & MD) and Adrian Di Marco (Company Founder, Executive Director and Executive Chairman).